Global Microarray Services Market Growth (Status and Outlook) 2026-2032
Description
The global Microarray Services market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Microarray Services involve laboratory techniques that utilize DNA, RNA, or protein microarrays to analyze gene expression, detect mutations, and study genetic variation on a high-throughput scale. In microarray analysis, thousands of small DNA probes are fixed onto a solid surface, like a glass slide or silicon chip, in a grid-like pattern. These probes can bind to complementary nucleic acid sequences in a sample, allowing scientists to study the presence, quantity, and activity of specific genes or proteins.
Ranking of major market players
GE Healthcare, Merck, Thermo Fisher Scientific, PerkinElmer, Illumina, Bio-Rad Laboratories, Agilent, Affymetrix, Arrayit, etc.
Market development opportunities and key drivers
The microarray services market is experiencing strong growth driven by advances in genomics, personalized medicine, and molecular diagnostics. With the growing demand for detailed genetic information, especially in areas such as oncology and rare disease research, microarray technology has become a valuable resource for comprehensive gene expression profiling, single nucleotide polymorphism (SNP) analysis, and epigenetic studies. Microarrays are able to analyze thousands of gene sequences in parallel, providing high-throughput data that is critical for precision medicine applications. The technology's ability to analyze complex genetic interactions and identify disease markers has driven its use in clinical diagnostics, contributing significantly to market growth. In addition, technological innovations such as next-generation microarrays with higher sensitivity and specificity are supporting the development of customized and customizable arrays to meet specific research needs, including agricultural and pharmacogenomics applications. Technological advances in microarrays are also contributing to market growth by improving data accuracy, sensitivity, and scalability. The rise of specialized microarrays tailored for specific applications, including DNA methylation and epigenetic studies, has enabled a deeper understanding of gene regulatory mechanisms, which is critical for studying diseases such as autoimmune diseases and cancer. In addition, the COVID-19 pandemic has accelerated the demand for microarray services as the technology can quickly perform genetic analysis of viruses and their variants, further validating the use of microarrays in infectious disease research. While the cost-effectiveness of microarrays compared to next-generation sequencing (NGS) has maintained its relevance, the continued reduction in NGS costs has created competitive pressure, prompting microarray service providers to focus on improving quality and providing comprehensive data interpretation services. As these technology and application-driven expansions are underway, the microarray services market is expected to maintain a strong growth trajectory, supported by increased research funding and government initiatives around the world.
LPI (LP Information)' newest research report, the “Microarray Services Industry Forecast” looks at past sales and reviews total world Microarray Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Microarray Services sales for 2026 through 2032. With Microarray Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microarray Services industry.
This Insight Report provides a comprehensive analysis of the global Microarray Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Microarray Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microarray Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microarray Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microarray Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Microarray Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Gene Expression Microarray
Genotyping Microarray
Methylation Microarray
Transcriptome Microarray
Segmentation by Application:
Medical Research
Drug Development
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Merck
Thermo Fisher Scientific
PerkinElmer
Illumina
Bio-Rad Laboratories
Agilent
Affymetrix
Arrayit
Psomagen
Hokkaido System Science
CD Genomics
OGT
Bionexus
LC Sciences
SCHOTT
Molecular Devices
Creative Biolabs
Please note: The report will take approximately 2 business days to prepare and deliver.
Microarray Services involve laboratory techniques that utilize DNA, RNA, or protein microarrays to analyze gene expression, detect mutations, and study genetic variation on a high-throughput scale. In microarray analysis, thousands of small DNA probes are fixed onto a solid surface, like a glass slide or silicon chip, in a grid-like pattern. These probes can bind to complementary nucleic acid sequences in a sample, allowing scientists to study the presence, quantity, and activity of specific genes or proteins.
Ranking of major market players
GE Healthcare, Merck, Thermo Fisher Scientific, PerkinElmer, Illumina, Bio-Rad Laboratories, Agilent, Affymetrix, Arrayit, etc.
Market development opportunities and key drivers
The microarray services market is experiencing strong growth driven by advances in genomics, personalized medicine, and molecular diagnostics. With the growing demand for detailed genetic information, especially in areas such as oncology and rare disease research, microarray technology has become a valuable resource for comprehensive gene expression profiling, single nucleotide polymorphism (SNP) analysis, and epigenetic studies. Microarrays are able to analyze thousands of gene sequences in parallel, providing high-throughput data that is critical for precision medicine applications. The technology's ability to analyze complex genetic interactions and identify disease markers has driven its use in clinical diagnostics, contributing significantly to market growth. In addition, technological innovations such as next-generation microarrays with higher sensitivity and specificity are supporting the development of customized and customizable arrays to meet specific research needs, including agricultural and pharmacogenomics applications. Technological advances in microarrays are also contributing to market growth by improving data accuracy, sensitivity, and scalability. The rise of specialized microarrays tailored for specific applications, including DNA methylation and epigenetic studies, has enabled a deeper understanding of gene regulatory mechanisms, which is critical for studying diseases such as autoimmune diseases and cancer. In addition, the COVID-19 pandemic has accelerated the demand for microarray services as the technology can quickly perform genetic analysis of viruses and their variants, further validating the use of microarrays in infectious disease research. While the cost-effectiveness of microarrays compared to next-generation sequencing (NGS) has maintained its relevance, the continued reduction in NGS costs has created competitive pressure, prompting microarray service providers to focus on improving quality and providing comprehensive data interpretation services. As these technology and application-driven expansions are underway, the microarray services market is expected to maintain a strong growth trajectory, supported by increased research funding and government initiatives around the world.
LPI (LP Information)' newest research report, the “Microarray Services Industry Forecast” looks at past sales and reviews total world Microarray Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Microarray Services sales for 2026 through 2032. With Microarray Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microarray Services industry.
This Insight Report provides a comprehensive analysis of the global Microarray Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Microarray Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microarray Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microarray Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microarray Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Microarray Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Gene Expression Microarray
Genotyping Microarray
Methylation Microarray
Transcriptome Microarray
Segmentation by Application:
Medical Research
Drug Development
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Merck
Thermo Fisher Scientific
PerkinElmer
Illumina
Bio-Rad Laboratories
Agilent
Affymetrix
Arrayit
Psomagen
Hokkaido System Science
CD Genomics
OGT
Bionexus
LC Sciences
SCHOTT
Molecular Devices
Creative Biolabs
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
131 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Microarray Services Market Size by Player
- 4 Microarray Services by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Microarray Services Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
